001     278658
005     20250601001327.0
024 7 _ |a 10.1128/mbio.03314-24
|2 doi
024 7 _ |a pmid:40167317
|2 pmid
024 7 _ |a pmc:PMC12077180
|2 pmc
024 7 _ |a 2161-2129
|2 ISSN
024 7 _ |a 2150-7511
|2 ISSN
024 7 _ |a altmetric:177345968
|2 altmetric
037 _ _ |a DZNE-2025-00614
041 _ _ |a English
082 _ _ |a 570
100 1 _ |a Chen, Yuexuan
|b 0
245 _ _ |a RAB5 is a host dependency factor for the generation of SARS-CoV-2 replication organelles.
260 _ _ |a Washington, DC
|c 2025
|b American Society for Microbiology
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1748429112_1773
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains a threat due to the emergence of variants with increased transmissibility and enhanced escape from immune responses. Like other coronaviruses before, SARS-CoV-2 likely emerged after its transmission from bats. The successful propagation of SARS-CoV-2 in humans might have been facilitated by usurping evolutionarily conserved cellular factors to execute crucial steps in its life cycle, such as the generation of replication organelles-membrane structures where coronaviruses assemble their replication-transcription complex. In this study, we found that RAB5, which is highly conserved across mammals, is a critical host dependency factor for the replication of the SARS-CoV-2 genome. Our results also suggest that SARS-CoV-2 uses RAB5+ membranes to build replication organelles with the aid of COPB1, a component of the COP-I complex, and that the virus protein NSP6 participates in this process. Hence, targeting NSP6 represents a promising approach to interfere with SARS-CoV-2 RNA synthesis and halt its propagation.IMPORTANCEIn this study, we sought to identify the host dependency factors that severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses for the generation of replication organelles: cellular membranous structures that SARS-CoV-2 builds in order to support the replication and transcription of its genome. We uncovered that RAB5 is an important dependency factor for SARS-CoV-2 replication and the generation of replication organelles, and that the viral protein NSP6 participates in this process. Hence, NSP6 represents a promising target to halt SARS-CoV-2 replication.
536 _ _ |a 351 - Brain Function (POF4-351)
|0 G:(DE-HGF)POF4-351
|c POF4-351
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a COP-I
|2 Other
650 _ 7 |a COPB1
|2 Other
650 _ 7 |a NSP6
|2 Other
650 _ 7 |a RAB5
|2 Other
650 _ 7 |a SARS-CoV-2
|2 Other
650 _ 7 |a replication organelle
|2 Other
650 _ 7 |a rab5 GTP-Binding Proteins
|0 EC 3.6.5.2
|2 NLM Chemicals
650 _ 7 |a RAB5C protein, human
|0 EC 3.6.1.-
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a rab5 GTP-Binding Proteins: metabolism
|2 MeSH
650 _ 2 |a rab5 GTP-Binding Proteins: genetics
|2 MeSH
650 _ 2 |a Virus Replication
|2 MeSH
650 _ 2 |a SARS-CoV-2: physiology
|2 MeSH
650 _ 2 |a SARS-CoV-2: genetics
|2 MeSH
650 _ 2 |a Animals
|2 MeSH
650 _ 2 |a COVID-19: virology
|2 MeSH
650 _ 2 |a Host-Pathogen Interactions
|2 MeSH
650 _ 2 |a Vero Cells
|2 MeSH
650 _ 2 |a Chlorocebus aethiops
|2 MeSH
650 _ 2 |a Viral Replication Compartments: metabolism
|2 MeSH
700 1 _ |a Klute, Susanne
|0 P:(DE-2719)9003510
|b 1
|u dzne
700 1 _ |a Sparrer, Konstantin Maria Johannes
|0 P:(DE-2719)9003481
|b 2
|u dzne
700 1 _ |a Serra-Moreno, Ruth
|0 0000-0002-1923-6414
|b 3
773 _ _ |a 10.1128/mbio.03314-24
|g Vol. 16, no. 5, p. e03314-24
|0 PERI:(DE-600)2557172-2
|n 5
|p e0331424
|t mBio
|v 16
|y 2025
|x 2161-2129
856 4 _ |u https://pub.dzne.de/record/278658/files/DZNE-2025-00614%20SUP.pdf
856 4 _ |y OpenAccess
|u https://pub.dzne.de/record/278658/files/DZNE-2025-00614.pdf
856 4 _ |x pdfa
|u https://pub.dzne.de/record/278658/files/DZNE-2025-00614%20SUP.pdf?subformat=pdfa
856 4 _ |y OpenAccess
|x pdfa
|u https://pub.dzne.de/record/278658/files/DZNE-2025-00614.pdf?subformat=pdfa
909 C O |o oai:pub.dzne.de:278658
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a External Institute
|0 I:(DE-HGF)0
|k Extern
|b 1
|6 P:(DE-2719)9003510
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 2
|6 P:(DE-2719)9003481
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-351
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Brain Function
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2024-12-18
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b MBIO : 2022
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0501
|2 StatID
|b DOAJ Seal
|d 2023-03-14T07:11:37Z
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0500
|2 StatID
|b DOAJ
|d 2023-03-14T07:11:37Z
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2024-12-18
915 _ _ |a Fees
|0 StatID:(DE-HGF)0700
|2 StatID
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2024-12-18
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b DOAJ : Anonymous peer review
|d 2023-03-14T07:11:37Z
915 _ _ |a Article Processing Charges
|0 StatID:(DE-HGF)0561
|2 StatID
|d 2024-12-18
915 _ _ |a IF >= 5
|0 StatID:(DE-HGF)9905
|2 StatID
|b MBIO : 2022
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2024-12-18
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2024-12-18
920 1 _ |0 I:(DE-2719)1910003
|k AG Sparrer
|l Neurovirology and Neuroinflammation
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-2719)1910003
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21